Moderna says Omicron-containing booster outperforms current vaccine
Moderna said Wednesday that using a new version of its Covid-19 vaccine as a booster led to a superior antibody response against the Omicron variant compared to its current shot.
The company said it plans to submit its data to the Food and Drug Administration in the coming weeks and that it hopes that the new booster will be available in the late summer.
Read Original Article: Moderna says Omicron-containing booster outperforms current vaccine »
